Half-Year Results
RNS Number : 0472M
Aseana Properties Limited
16 September 2021
16 September 2021
Aseana Properties Limited
("Aseana", the "Company" or, the "Group")
Half-Year Results for the Six Months Ended 30 June 2021
Aseana Properties Limited (LSE: ASPL), a property developer with investments in Malaysia and Vietnam, listed on the Main Market of the London Stock Exchange, announces its unaudited half-year results for the six-month period ended 30 June 2021.
Operational summary:
· The RuMa Residences have been approximately 71% sold to date based on sale and purchase agreements signed.
· The RuMa Hotel was temporarily closed for 60 days in two different periods due to MCO and achieved an average occupancy rate of approximately 11% in the first six months of 2021. Losses for the six months ending 30th June was approximately 4.6m MYR in line with the budget; second half results will decline resulting from closure of the hotel due to MCO. The hotel has now re-opened but uncertainty remains as the hotel may be subjected to further closure under any future MCO's as mandated by Malaysian government.
· In the first half year of 2021, The Harbour Mall Sandakan performance has exceeded expectations with occupancy rates at about 95%. The mall operator has continued to rebate rental lease payments to tenants during the prevailing MCO as a measure to support the tenants and to retain the occupancy levels. Financial performance through June 30th, 2021 reflects expectations however if MCO continues into the latter half of 2021 financial performance will suffer.
· City International Hospital has been negatively affected by Covid, similar to other hospitals in Vietnam and specifically Ho Chi Minh City ("HCM"). In the first 6 months, revenue decreased about 27% against budget, with overall EBITDA declining by approximately 57% against budget. Since December 2020, management have undertaken cost cutting measures across the board including instituting a hiring freeze, reviewing profit margins and productivity of staff. Performance is expected to improve in the second half as cost savings are realised, however, the Vietnam government mandated total lockdown of HCM in August, this mandate was expected to be gradually lifted starting 15th September, 2021 but has now been extended to month end.
· As reported in our Annual Report issued 2nd August, 2021, it is expected that the Group would be financed via the disposal of its investments in Vietnam, the sale of the remaining existing units of residential inventories at The RuMa Hotel & Residences in West Malaysia, and through the disposals of the Sandakan hotel asset (formerly Four Points Sheraton Sandakan Hotel), the Harbour Mall Sandakan and the RuMa Hotel. The Divestment Team has been actively seeking for potential purchasers.
Financial summary:
· Other Income of US$7.7 million (H1 2020: US$8.6 million)
· Loss before tax of US$3.2 million (H1 2020: loss of US$8.2 million)
· Loss after tax of US$3.3 million (H1 2020: loss of US$8.3 million)
· Total comprehensive loss of US$6.6 million (H1 2020: loss of US$11.1 million)
· Net asset value of US$96.7 million (31 December 2020 (audited): US$101.3 million) or US$0.49 per share (31 December 2020 (audited): US$0.51 per share)
Subsequent Events:
On 25th August, 2021 the Company announced that it had entered into a binding agreement to sell its entire interest in both the City International Hospital and the adjacent International Healthcare Park in HCM. The terms of the transaction are subject to approvals from regulatory authorities as well as conditions to completion. It is expected the completion will take several months. Once completed, the Company will have no assets in Vietnam.
On 9th September, 2021 the Company announced it had entered into a conditional agreement to sell the remaining 58 unsold residential units at The Ruma Hotel & Residences in Kuala Lumpur. Gross sale price is MYR 85.3m (approximately US $20.5m) and is subject to final due diligence by the Buyer as well as receipt of government approval for the sale to a foreign investor. Expected completion will take place within 8 months.
Commenting on the results, Nick Paris, Chairman of Aseana, said:
"The H1 2021 results show that Aseana has still had to deal with challenging market conditions in both Malaysia and Vietnam resulting from the negative impact of COVID 19 and the movement controls introduced by the respective governments to contain the spread of the virus. Nonetheless, the Company has continued to focus on improving the operational performance and narrowing the losses of its operating assets. Since the end of this period we have started to see the results of our divestment activities and we have signed two sale and purchase agreements covering our assets in Vietnam and our high end residences in Kuala Lumpur, Further asset sales are being actively worked on."
For further information:
| Aseana Properties Limited | Tel: 020 3325 7050 |
| Nick Paris (Chairman) | Email: nick.paris@limadvisors.com |
| Liberum Capital | Tel: 020 3100 2000 |
| Darren Vickers / Owen Matthews | Email: aseana@liberum.com |
| Project | Type | Effective Ownership | Approximate Gross Floor Area (sq m) | Approximate Land Area (sq m) |
| The RuMa Hotel & Residences Kuala Lumpur, Malaysia | Luxury residential tower and bespoke hotel | 70.0% | 40,000 | 4,000 |
| Sandakan Harbour Square Sandakan, Sabah, Malaysia | Hotel and retail mall | 100.0% | 126,000 | 48,000 |
| City International Hospital, International Healthcare Park, Ho Chi Minh City, Vietnam | Private general hospital | 73.04%* | 48,000 | 25,000 |
| Undeveloped projects | ||||
| Other developments in International Healthcare Park, Ho Chi Minh City, Vietnam (formerly International Hi-Tech Healthcare Park) | Commercial and residential development with healthcare theme | 73.04%* | 972,000 | 351,000 |
| Kota Kinabalu Seafront resort & residences Kota Kinabalu, Sabah, Malaysia | Resort homes | 80.0% | n/a | 327,000 |
| Unaudited | Unaudited | Audited | ||
| Notes | Six months ended 30 June | Six months ended 30 June | Year ended 31 December | |
| 2021 | 2020 | 2020 | ||
| Continuing activities | US$'000 | US$'000 | US$'000 | |
| Revenue | 3 | 516 | - | 1,329 |
| Cost of sales | 5 | (416) | (3) | (950) |
| Gross profit/(loss) | 100 | (3) | 379 | |
| Other income | 7,743 | 8,581 | 18,271 | |
| Administrative expenses | (418) | (637) | (1,658) | |
| Foreign exchange gain/(loss) | 6 | 852 | (1,023) | (1,051) |
| Loss on disposal of subsidiaries | - | - | (784) | |
| Marketing expenses | - | (11) | - | |
| Other operating expenses | (8,585) | (11,647) | (20,657) | |
| Operating loss | (308) | (4,740) | (5,500) | |
| Finance income | 1,399 | 882 | 3,323 | |
| Finance costs | (4,311) | (4,426) | (11,152) | |
| Net finance costs | (2,912) | (3,544) | (7,829) | |
| Net loss before taxation | (3,220) | (8,284) | (13,329) | |
| Taxation | 7 | (38) | (4) | (187) |
| Loss for the period/year | (3,258) | (8,288) | (13,516) | |
| Other comprehensive (loss)/ income, net of tax Items that are or may be reclassified subsequently to profit or loss | ||||
| Foreign currency translation differences for foreign operations | (3,316) | (2,873) | 2,078 | |
| Total other comprehensive (loss)/income for the period/year | (3,316) | (2,873) | 2,078 | |
| Total comprehensive loss for the period/year | (6,574) | (11,161) | (11,438) | |
| Loss attributable to: Equity holders of the parent | (1,733) | (6,485) | (10,260) | |
| Non-controlling interests | (1,525) | (1,803) | (3,256) | |
| Total | (3,258) | (8,288) | (13,516) | |
| Total comprehensive loss attributable to: | ||||
| Equity holders of the parent | (4,690) | (9,345) | (8,371) | |
| Non-controlling interests | (1,884) | (1,816) | (3,067) | |
| Total | (6,574) | (11,161) | (11,438) | |
| Loss per share Basic and diluted (US cents) | (0.87) | (3.26) | (5.16) |
| Unaudited | Unaudited | Audited | ||
| Notes | As at 30 June | As at 30 June | As at 31 December | |
| 2021 | 2020 | 2020 | ||
| US$'000 | US$'000 | US$'000 | ||
| Non-current assets | ||||
| Property, plant and equipment | 527 | 593 | 565 | |
| Intangible assets | 4,097 | 4,097 | 4,097 | |
| Right of use | 17 | 360 | 160 | |
| Deferred tax assets | 4,944 | 4,842 | 5,111 | |
| Total non-current assets | 9,585 | 9,892 | 9,933 | |
| Current assets | ||||
| Inventories | 232,576 | 232,753 | 237,394 | |
| Trade and other receivables | 15,400 | 17,746 | 16,211 | |
| Prepayments | 354 | 606 | 415 | |
| Current tax assets | 923 | 3 | 956 | |
| Cash and cash equivalents | 9,722 | 5,226 | 5,948 | |
| Total current assets | 258,975 | 256,334 | 260,924 | |
| TOTAL ASSETS | 268,560 | 266,226 | 270,857 | |
| Equity | ||||
| Share capital | 10,601 | 10,601 | 10,601 | |
| Share premium | 208,925 | 208,925 | 208,925 | |
| Capital redemption reserve | 1,899 | 1,899 | 1,899 | |
| Translation reserve | (22,612) | (24,504) | (19,655) | |
| Accumulated losses | (102,166) | (96,630) | (100,433) | |
| Shareholders' equity | 96,647 | 100,291 | 101,337 | |
| Non-controlling interests | (8,761) | (5,654) | (6,877) | |
| Total equity | 87,886 | 94,637 | 94,460 | |
| Non-current liabilities | ||||
| Trade and other payable | 38,507 | 37,518 | 39,789 | |
| Loans and borrowings | 9 | 26,634 | 25,318 | 21,926 |
| Total non-current liabilities | 65,141 | 62,836 | 61,715 | |
| Current liabilities | ||||
| Trade and other payables | 33,511 | 30,681 | 33,300 | |
| Amount due to non-controlling interests | 11,588 | 10,923 | 11,371 | |
| Loans and borrowings | 9 | 26,986 | 28,182 | 29,811 |
| Medium term notes | 10 | 43,448 | 37,878 | 40,200 |
| Current tax liabilities | - | 1,089 | - | |
| Total current liabilities | 115,533 | 108,753 | 114,682 | |
| Total liabilities | 180,674 | 171,589 | 176,397 | |
| TOTAL EQUITY AND LIABILITIES | 268,560 | 266,226 | 270,857 |
| Redeemable Ordinary Shares US$'000 | Management Shares US$'000 | Share Premium US$'000 | Capital Redemption Reserve US$'000 | Translation Reserve US$'000 | Accumulated Losses US$'000 | Total Equity Attributable to Equity Holders of the Parent US$'000 | Non- Controlling Interests US$'000 | Total Equity US$'000 | |
| 1 January 2021 | 10,601 | - | 208,925 | 1,899 | (19,655) | (100,433) | 101,337 | (6,877) | 94,460 |
| Loss for the period | - | - | - | - | - | (1,733) | (1,733) | (1,525) | (3,258) |
| Total other comprehensive loss | - | - | - | - | (2,957) | - | (2,957) | (359) | (3,316) |
| Total comprehensive loss | - | - | - | - | (2,957) | (1,733) | (4,690) | (1,884) | (6,574) |
| Shareholders' equity at 30 June 2021 | 10,601 | - | 208,925 | 1,899 | (22,612) | (102,166) | 96,647 | (8,761) | 87,886 |
| Redeemable Ordinary Shares US$'000 | Management Shares US$'000 | Share Premium US$'000 | Capital Redemption Reserve US$'000 | Translation Reserve US$'000 | Accumulated Losses US$'000 | Total Equity Attributable to Equity Holders of the Parent US$'000 | Non- Controlling Interests US$'000 | Total Equity US$'000 | |
| 1 January 2020 | 10,601 | - | 208,925 | 1,899 | (21,644) | (90,135) | 109,646 | (3,848) | 105,798 |
| Loss for the period | - | - | - | - | - | (6,485) | (6,485) | (1,803) | (8,288) |
| Total other comprehensive loss | - | - | - | - | (2,860) | - | (2,860) | (13) | (2,873) |
| Total comprehensive loss | - | - | - | - | (2,860) | (6,485) | (9,345) | (1,816) | (11,161) |
| Change in ownership of subsidiaries | - | - | - | - | - | (10) | (10) | 10 | - |
| Shareholders' equity at 30 June 2020 | 10,601 | - | 208,925 | 1,899 | (24,504) | (96,630) | 100,291 | (5,654) | 94,637 |
| Consolidated | Redeemable Ordinary Shares US$'000 | Management Shares US$'000 | Share Premium US$'000 | Capital Redemption Reserve US$'000 | Translation Reserve US$'000 | Accumulated Losses US$'000 | Total Equity Attributable to Equity Holders of the Parent US$'000 | Non- Controlling Interests US$'000 | Total Equity US$'000 |
| Balance at 1 January 2019 | 10,601 | - | 208,925 | 1,899 | (22,265) | (63,005) | 136,155 | (966) | 135,189 |
| Changes in ownership interests in subsidiaries | - | - | - | - | - | (24) | (24) | 24 | - |
| Loss for the year | - | - | - | - | - | (27,106) | (27,106) | (2,900) | (30,006) |
| Total other comprehensive loss for the year | - | - | - | - | 621 | - | 621 | (6) | 615 |
| Total comprehensive loss for the year | - | - | - | - | 621 | (27,106) | (26,485) | (2,906) | (29,391) |
| As at 31 December 2019/ 1 January 2020 | 10,601 | - | 208,925 | 1,899 | (21,644) | (90,135) | 109,646 | (3,848) | 105,798 |
| Adjusted balance at 31 December 2019 / 1 January 2020 | 10,601 | -# | 208,925 | 1,899 | (21,644) | (90,135) | 109,646 | (3,848) | 105,798 |
| Changes in ownership interests in subsidiaries | - | - | - | - | - | (38) | (38) | 38 | - |
| Loss for the year | - | - | - | - | - | (10,260) | (10,260) | (3,256) | (13,516) |
| Total other comprehensive loss for the year | - | - | - | - | 1,889 | - | 1,889 | 189 | 2,078 |
| Total comprehensive loss for the year | - | - | - | - | 1,889 | (10,260) | (8,371) | (3,067) | (11,438) |
| Disposal of subsidiaries | - | - | - | - | 100 | - | 100 | - | 100 |
| Shareholders' equity at 31 December 2020 | 10,601 | -# | 208,925 | 1,899 | (19,655) | (100,433) | 101,337 | (6,877) | 94,460 |
| Unaudited | Unaudited | Audited | |
| Six months | Six months | Year | |
| ended 30 June | ended 30 June | ended 31 December | |
| 2021 | 2020 | 2020 | |
| US$'000 | US$'000 | US$'000 | |
| Cash Flows from Operating Activities | |||
| Loss before taxation | (3,220) | (8,284) | (13,329) |
| Finance income | (1,399) | (882) | (3,323) |
| Finance costs | 4,311 | 4,426 | 11,151 |
| Loss on disposal of subsidiaries | - | - | 784 |
| Unrealised foreign exchange gain | 1,736 | 998 | (546) |
| Write down/Impairment of goodwill | - | - | - |
| Depreciation of property, plant and equipment and right-of-use asset | 187 | 46 | 479 |
| Net realisation value adjustments of inventory | - | - | - |
| Operating (loss)/profit before changes in working capital | 1,615 | (3,696) | (4,784) |
| Changes in working capital: | |||
| Decrease /(Increase) in inventories | (753) | (4,287) | 856 |
| Decrease /(Increase) in trade and other receivables and prepayments | 716 | (5,442) | (2,607) |
| (Decrease) /Increase in trade and other payables | (1,326) | 6,929 | 8,164 |
| Cash used in operations | 252 | (6,496) | 1,629 |
| Interest paid | (4,299) | (4,426) | (9,932) |
| Tax paid | (36) | (122) | (2,309) |
| Net cash used in operating activities | (4,083) | (11,044) | (10,612) |
| Cash Flows From Investing Activities | |||
| Proceeds from disposal of property, plant and equipment | - | 6 | - |
| Purchase of property, plant and equipment | (14) | (25) | (39) |
| Proceeds from disposal of subsidiaries | - | - | 3,936 |
| Finance income received | 1,399 | 882 | 3,012 |
| Net cash from investing activities | 1,385 | 863 | 6,910 |
| Unaudited | Unaudited | Audited | |
| Six months | Six months | Year | |
| ended June | ended 30 June | ended 31 December | |
| 2021 | 2020 | 2020 | |
| US$'000 | US$'000 | US$'000 | |
| Cash Flows From Financing Activities | |||
| Advances (from)/to non-controlling interests | 303 | 578 | 728 |
| Repayment of finance lease liabilities | (227) | (40) | (463) |
| Repayment of loans and borrowings | (481) | (2,496) | (4,879) |
| Drawdown of loans and borrowings and medium term notes | 7,085 | 9,603 | 6,526 |
| Net decrease in pledged deposits for loans and borrowings and Medium Term Notes | - | 1,703 | 75 |
| Net cash from financing activities | 6,680 | 9,348 | 1,987 |
| Net changes in cash and cash equivalents during the period/year | 3,982 | (833) | (1,715) |
| Effect of changes in exchange rates | (208) | 322 | 48 |
| Cash and cash equivalents at the beginning of the period/year (i) | 5,948 | 3,235 | 7,615 |
| Cash and cash equivalents at the end of the period/year (i) | 9,722 | 2,724 | 5,948 |
| Unaudited | Unaudited | Audited | |
| Six months | Six months | Year | |
| ended June | ended 30 June | ended 31 December | |
| 2021 | 2020 | 2020 | |
| US$'000 | US$'000 | US$'000 | |
| Cash and bank balances | 7,261 | 2,105 | 3,052 |
| Short term bank deposits | 2,461 | 3,121 | 2,896 |
| 9,722 | 5,226 | 5,948 | |
| Less: Deposits pledged (ii) | (2,174) | (2,502) | (2,619) |
| Cash and cash equivalents | 7,548 | 2,724 | 3,329 |
Investment Holding Companies | Ireka Land Sdn. Bhd. | ICSD Ventures Sdn. Bhd. | Amatir Resources Sdn. Bhd. | The RuMa Hotel KL Sdn. Bhd. | Urban DNA Sdn. Bhd. | Hoa Lam-Shangri-La Healthcare Group | Total | |
| US$'000 | US$'000 | US$'000 | US$'000 | US$'000 | US$'000 | US$'000 | US$'000 | |
| Segment (loss)/profit before taxation | (1,745) | - | (223) | 227 | (1,128) | (1,143) | (1,795) | (5,807) |
| Included in the measure of segment (loss)/profit are: | ||||||||
| Revenue | - | - | - | - | - | 516 | - | 516 |
| Cost of sales | - | - | - | - | - | (416) | - | (416) |
| Revenue from hotel operations | - | - | - | - | 1,005 | - | - | 1,005 |
| Revenue from mall operations | - | - | 945 | - | - | - | - | 945 |
| Revenue from hospital operations | - | - | - | - | - | - | 5,574 | 5,574 |
| Expenses from hotel operations | - | - | (27) | - | (1,967) | - | - | (1,994) |
| Expenses from mall operations | - | - | (636) | - | - | - | - | (636) |
| Expenses from hospital operations | - | - | - | - | - | - | (5,304) | (5,304) |
| Depreciation of property, plant and equipment | - | - | (26) | - | (139) | - | (16) | (181) |
| Finance costs | - | - | (585) | (102) | - | (869) | (2,037) | (3,593) |
| Finance income | 356 | - | 22 | 336 | - | 11 | 1 | 726 |
| Segment assets | 5,141 | 132 | 58,906 | 3,192 | 648 | 103,929 | 86,423 | 258,371 |
| Segment liabilities | 11,500 | 3 | 1,806 | 2,806 | 2,091 | 49,686 | 67,793 | 135,685 |
| Profit or loss | US$'000 |
| Total loss for reportable segments | (5,807) |
| Other non-reportable segments | 2,632 |
| Finance income | 673 |
| Others | (718) |
| (5,807) | |
| Consolidated loss before taxation | (3,220) |
Investment Holding Companies | Ireka Land Sdn. Bhd. | ICSD Ventures Sdn. Bhd. | Amatir Resources Sdn. Bhd. | The RuMa Hotel KL Sdn. Bhd. | Urban DNA Sdn. Bhd. | Hoa Lam-Shangri-La Healthcare Group | Total | |
| US$'000 | US$'000 | US$'000 | US$'000 | US$'000 | US$'000 | US$'000 | US$'000 | |
| Segment (loss)/profit before taxation | (1,660) | 4 | (1,470) | 18 | (1,518) | (1,227) | (2,397) | (8,250) |
| Included in the measure of segment profit/(loss) are: | ||||||||
| Revenue | - | - | - | - | - | - | - | - |
| Revenue from hotel operations | - | - | 647 | - | 1,504 | - | - | 2,151 |
| Revenue from mall operations | - | - | 731 | - | - | - | - | 731 |
| Revenue from hospital operations | - | - | - | - | - | - | 5,615 | 5,615 |
| Marketing expenses | - | - | - | - | - | (11) | - | (11) |
| Expenses from hotel operations | - | - | (1,744) | - | (2,814) | - | - | (4,558) |
| Expenses from mall operations | - | - | (473) | - | - | - | - | (473) |
| Expenses from hospital operations | - | - | - | - | - | - | (5,680) | (5,680) |
| Depreciation of property, plant and equipment | - | - | - | - | (23) | - | (23) | (46) |
| Finance costs | - | - | (701) | (169) | - | (1,383) | (2,173) | (4,426) |
| Finance income | - | 1 | 49 | 209 | - | 21 | 7 | 287 |
| Segment assets | 3,833 | 351 | 57,231 | 6,025 | 1,486 | 82,387 | 86,754 | 2387,067 |
| Segment liabilities | 164 | 180 | 2,783 | 3,867 | 2,399 | 9,993 | 66,857 | 86,243 |
| Profit or loss | US$'000 |
| Total loss for reportable segments | (8,250) |
| Other non-reportable segments | (34) |
| Consolidated loss before taxation | (8,284) |
| Investment Holding Companies | Ireka Land Sdn. Bhd. | ICSD Ventures Sdn. Bhd. | Amatir Resources Sdn. Bhd. | The RuMa Hotel KL Sdn. Bhd. | Urban DNA Sdn. Bhd. | Hoa Lam Shangri-La Healthcare Group | Total | |
| US$'000 | US$'000 | US$'000 | US$'000 | US$'000 | US$'000 | US$'000 | US$'000 | |
| Segment (loss)/profit before taxation | (1,483) | 14 | (1,314) | 171 | (2,774) | (1,976) | (4,208) | (11,570) |
| Included in the measure of segment (loss)/profit are: | ||||||||
| Revenue | - | - | - | - | - | 1,329 | - | 1,392 |
| Other income from hotel operations | - | - | 655 | - | 2,323 | - | - | 2,978 |
| Other income from mall operations | - | - | 1,754 | - | - | - | - | 1,754 |
| Other income from hospital operations | - | - | - | - | - | - | 11,800 | 11,800 |
| Expenses from hotel operations | - | - | (1,814) | - | (4,638) | - | - | (6,452) |
| Expenses from mall operations | - | - | (1,380) | - | - | - | - | (1,380) |
| Expenses from hospital operations | - | - | - | - | - | - | (11,094) | (11,094) |
| Depreciation of property, plant and equipment | - | - | - | - | (48) | - | (47) | (95) |
| Finance costs | - | - | (1,517) | (326) | - | (1,635) | (6,425) | (9,903) |
| Finance income | 310 | - | 68 | 456 | - | 22 | 1,218 | 2,074 |
| Segment assets | 4,464 | 203 | 60,999 | 3,094 | 1,255 | 104,524 | 86,169 | 260,708 |
| Segment liabilities | 596 | 3 | 1,911 | 1,138 | 2,277 | 51,087 | 16,568 | 73,580 |
| Profit or loss | US$'000 |
| Total loss for reportable segments | (11,570) |
| Other non-reportable segments | (1,759) |
| Finance income | 1,249 |
| Others | (1,249) |
| Consolidated loss before taxation | (13,329) |
| 3 SegmentAL Information (continued) Six months ended 30 June 2021 - Unaudited | |||||||
US$'000 | Revenue | Depreciation | Finance costs | Finance income | Segment assets | Segment liabilities | Addition to non-current assets |
| Total reportable segment | 516 | 96 | (3,593) | 680 | 258,372 | 126,003 | 15 |
| Other non-reportable segments | - | (144) | (718) | 719 | 10,189 | 54,673 | - |
| Consolidated total | 516 | (48) | (4,311) | 1,399 | 268,561 | 180,676 | 15 |
| 3 SegmentAL Information (continued) Six months ended 30 June 2020 - Unaudited | |||||||
US$'000 | Revenue | Depreciation | Finance costs | Finance income | Segment assets | Segment liabilities | Addition to non-current assets |
| Total reportable segment | - | (46) | (4,426) | 287 | 238,067 | 86,243 | - |
| Other non-reportable segments | - | - | - | 595 | 28,159 | 85,346 | 25 |
| Consolidated total | - | (46) | (4,426) | 882 | 266,226 | 171,589 | 25 |
| 3 SegmentAL Information (continued) Year ended 31 December 2020 -Audited | |||||||
| US$'000 | Revenue | Depreciation | Finance costs | Finance income | Segment assets | Segment liabilities | Additions to non-current assets |
| Total reportable segment | 1,329 | (461) | (9,903) | 2,074 | 260,708 | 73,580 | 39 |
| Other non-reportable segments | - | 366 | (1,249) | 1,249 | 10,149 | 102,817 | - |
| Consolidated total | 1,329 | (95) | (11,152) | 3,323 | 270,857 | 176,397 | 39 |
| Malaysia | Vietnam | Consolidated | |
| US$'000 | US$'000 | US$'000 | |
| Revenue | 516 | - | 516 |
| Non-current assets | 9,164 | 422 | 9,586 |
| Malaysia | Vietnam | Consolidated | |
| US$'000 | US$'000 | US$'000 | |
| Revenue | - | - | - |
| Non-current assets | 5,907 | 3,985 | 9,892 |
| Malaysia | Vietnam | Consolidated | |
| US$'000 | US$'000 | US$'000 | |
| Revenue | 1,329 | - | 1,329 |
| Non-current assets | 9,489 | 444 | 9,933 |
| Unaudited | Unaudited | Audited | |
| Six months | Six months | Year | |
| ended 30 June | ended 30 June | ended 31 December | |
| 2021 | 2020 | 2020 | |
| US$'000 | US$'000 | US$'000 | |
| Direct costs attributable to: | |||
| Completed Units | 416 | 3 | 950 |
| 416 | 3 | 950 |
| Unaudited | Unaudited | Audited | |
| Six months | Six months | Year | |
| ended 30 June | ended 30 June | ended 31 December | |
| 2021 | 2020 | 2020 | |
| US$'000 | US$'000 | US$'000 | |
| Foreign exchange gain/(loss) comprises: | |||
| Realised foreign exchange loss | (3) | (25) | (24) |
| Unrealised foreign exchange gain/(loss) | 855 | (998) | (1,027) |
| 852 | (1,023) | (1,051) |
| Unaudited | Unaudited | Audited | |
| Six months | Six months | Year | |
| ended 30 June | ended 30 June | ended 31 December | |
| 2021 | 2020 | 2020 | |
| US$'000 | US$'000 | US$'000 | |
| Current tax expense | 38 | 4 | 139 |
| Deferred tax credit | - | - | 48 |
| Total tax expense/(income) for the period/year | 38 | 4 | 187 |
| Unaudited | Unaudited | Audited | |
| Six months | Six months | Year | |
| ended 30 June | ended 30 June | ended 31 December | |
| 2021 | 2020 | 2020 | |
| US$'000 | US$'000 | US$'000 | |
| Net loss before taxation | (3,220) | (8,284) | (13,329) |
Income tax at rate of 24% | (773) | (1,988) | (3,199) |
| Add : | |||
| Tax effect of expenses not deductible in determining taxable profit | 759 | 3,274 | 3,781 |
| Current year losses and other tax benefits for which no deferred tax asset was recognised | 406 | 687 | 3,076 |
| Tax effect of different tax rates in subsidiaries | 361 | 476 | 162 |
| Less : | |||
| Tax effect of income not taxable in determining taxable profit | (715) | (2,064) | (3,752) |
| (Under)/Over provision in respect of prior period/year | - | (381) | 119 |
| Total tax expense for the period/year | 38 | 4 | 187 |
| Unaudited | Unaudited | Audited | |
| Six months | Six months | Year | |
| ended 30 June | ended 30 June | ended 31 December | |
| 2021 | 2020 | 2020 | |
| Loss attributable to equity holders of the parent (US$'000) | (1,732) | (6,485) | (10,216) |
| Weighted average number of shares | 198,691,000 | 198,691,000 | 198,691,000 |
| Loss per share | |||
| Basic and diluted (US cents) | (0.87) | (3.26) | (5.16) |
| Unaudited | Unaudited | Audited | ||
| As at 30 June | As at 30 June | As at 31 December | ||
| 2021 | 2020 | 2020 | ||
| US$'000 | US$'000 | US$'000 | ||
| Non-current | ||||
| Bank loans | 26,634 | 25,165 | 21,925 | |
| Finance lease liabilities | - | 153 | 1 | |
| 26,634 | 25,318 | 21,926 | ||
| Current | ||||
| Bank loans | 26,943 | 27,949 | 29,631 | |
| Finance lease liabilities | 43 | 233 | 180 | |
| 26,986 | 28,182 | 29,811 | ||
| 53,620 | 53,500 | 51,737 |
| As at 1 January 2021 | Drawdown of loan | Repayment of loan | Foreign exchange movements | As at 30 June 2021 | |
| Unaudited | US$'000 | US$'000 | US$'000 | US$'000 | US$'000 |
| Bank loans | 51,556 | 2,674 | (481) | (172) | 53,577 |
| Total | 51,556 | 2,674 | (481) | (172) | 53,577 |
| As at 1 January 2020 | Drawdown of loan | Repayment of loan | Foreign exchange movements | As at 30 June 2020 | |
| Unaudited | US$'000 | US$'000 | US$'000 | US$'000 | US$'000 |
| Bank loans | 53,070 | 6,998 | (2,496) | (4,072) | 53,500 |
| Total | 53,070 | 6,998 | (2,496) | (4,072) | 53,500 |
| As at 1 January 2020 | Drawdown of loan | Repayment of loan | Foreign exchange movements | As at 31 December 2020 | |
| Audited | US$'000 | US$'000 | US$'000 | US$'000 | US$'000 |
| Bank loans | 53,070 | 3,148 | (4,879) | 217 | 51,556 |
| Total | 53,070 | 3,148 | (4,879) | 217 | 51,556 |
| As at 1 January 2021 | Repayment of lease payment | Interest expenses | Foreign exchange movements | As at 30 June 2021 | |
| Unaudited | US$'000 | US$'000 | US$'000 | US$'000 | US$'000 |
| Lease Liabilities | 181 | (227) | 12 | 77 | 43 |
| Total | 181 | (227) | 12 | 77 | 43 |
| As at 1 January 2020 | Repayment of lease payment | Interest expenses | Foreign exchange movements | As at 30 June 2020 | |
| Unaudited | US$'000 | US$'000 | US$'000 | US$'000 | US$'000 |
| Lease Liabilities | 611 | (224) | - | (1) | 386 |
| Total | 611 | (224) | - | (1) | 386 |
| As at 1 January 2020 | Repayment of lease payment | Interest expenses | Foreign exchange movements | As at 31 December 2020 | |
| Audited | US$'000 | US$'000 | US$'000 | US$'000 | US$'000 |
| Lease Liabilities | 611 | (463) | 23 | 10 | 181 |
| Total | 611 | (463) | 23 | 10 | 181 |
| Unaudited | Unaudited | Audited | |
| As at | As at | As at | |
| 30 June | 30 June | 31 December | |
| 2021 | 2020 | 2020 | |
| US$'000 | US$'000 | US$'000 | |
| Outstanding medium term notes | 43,609 | (38,060) | 40,570 |
| Net transaction costs | (161) | (182) | (370) |
| Less: | |||
| Repayment due within twelve months* | (43,448) | (37,878) | (40,200) |
| Repayment due after twelve months | - | - | - |
| As at 1 January 2021 | Drawdown of loan | Non-cash adjustment | Foreign exchange movements | As at 30 June 2021 | |
| Unaudited | US$'000 | US$'000 | US$'000 | US$'000 | US$'000 |
| Medium Term Notes | 40,200 | 4,411 | 200 | (1,363) | 43,448 |
| As at 1 January 2020 | Drawdown of loan | Repayment of loan | Foreign exchange movements | As at 30 June 2020 | |
| Unaudited | US$'000 | US$'000 | US$'000 | US$'000 | US$'000 |
| Medium Term Notes | 36,142 | 2,605 | - | (869) | 37,787 |
| As at 1 January 2020 | Drawdown of loan | Repayment of loan | Foreign exchange movements | As at 31 December 2020 | |
| Audited | US$'000 | US$'000 | US$'000 | US$'000 | US$'000 |
| Medium Term Notes | 36,142 | 3,378 | - | 680 | 40,200 |
| Maturity Dates | Interest rate % per annum | US$'000 | |
| Series 1 Tranche FGI | 8 Dec 2021 | 6.02 | 13,726 |
| Series 1 Tranche BG | 8 Dec 2021 | 6.02 | 10,354 |
| 24,080 |
| Initial Issue | First Rolled-over | Second Rolled-over | ||||||
| Tranche Number | Date | RM ('000) | Tranche Number | Date | RM ('000) | Tranche Number | Date | RM ('000) |
| Tranche 1-23 | 10 Jun 2019 | 22,850 | Tranche 63-83 | 10 Jun 2020 | 20,950 | Tranche 124-142 | 10 Jun 2021 | 20,950 |
| Tranche 24-31 | 30 Sep 2019 | 9,600 | Tranche 84-91 | 30 Sep 2020 | 9,600 | |||
| Tranche 32-49 | 7 Oct 2019 | 17,100 | Tranche 92-109 | 7 Oct 2020 | 17,100 | |||
| Tranche 50-62 | 25 Feb 2020 | 15,350 | Tranche 110-122 | 25 Feb 2021 | 15,350 | |||
| Tranche 123 | 9 Jun 2021 | 18,100 | ||||||
| Maturity Dates | Interest rate % per annum | US$'000 | |
| Tranche 84-91 | 1 Oct 2021 | 6.0 | 2,312 |
| Tranche 92-109 | 8 Oct 2021 | 6.0 | 4,118 |
| Tranche 110-122 | 28Feb 2022 | 6.0 | 3,696 |
| Tranche 123 | 10Jun 2022 | 7.0 | 4,358 |
| Tranche 124-142 | 13Jun 2022 | 6.0 | 5,045 |
| 19,529 |
| Unaudited | Unaudited | Audited | |
| Six months | Six months | Year | |
| ended 30 June | ended 30 June | ended 31 December | |
| 2021 | 2020 | 2020 | |
| US$'000 | US$'000 | US$'000 | |
| ICB Group of Companies | |||
| Accounting and financial reporting services fee charged by an ICB subsidiary | - | 208 | - |
| Accrued interest on shareholders advance payable by ICB | 356 | - | 227 |
| Accrued interest on a contract payment by an ICB subsidiary | 70 | - | 83 |
| Construction progress claim charged by ICB subsidiary | - | 604 | - |
| Hosting and IT support services charged by an ICB subsidiary | 2 | 38 | - |
| Marketing commission charged by an ICB subsidiary | 7 | 8 | - |
| Rental expenses charge by an ICB subsidiary | 29 | 36 | - |
| Secretarial and administrative services fee charged by an ICB subsidiary | - | 371 | - |
| Key management personnel | |||
| Remuneration of key management personnel - Directors' fees | 146 | 312 | 233 |
| Remuneration of key management personnel - Salaries | 125 | 47 | 67 |
| Unaudited | Unaudited | Audited | |
| Six months | Six months | Year | |
| ended 30 June | ended 30 June | ended 31 December | |
| 2021 | 2020 | 2020 | |
| US$'000 | US$'000 | US$'000 | |
| Non-controlling interests | |||
| Advances - non-interest bearing Other related parties | 193 | 578 | 731 |
| Disposal of subsidiaries | - | - | 3,936 |
| Unaudited As at 30 June 2021 US$'000 | Unaudited As at 30 June 2020 US$'000 | Audited As at 31 December 2020 US$'000 | |
| Net amount due from an ICB subsidiary | 1,945 | 4,555 | 1,953 |
| Net amount due from ICB | 5,109 | 3,692 | 3,381 |
| Unaudited As at 30 June 2021 | Unaudited As at 30 June 2020 | Audited As at 31 December 2020 | |
| US$'000 | US$'000 | US$'000 | |
| Non-controlling interests | |||
| Advances - non-interest bearing | (10,830) | (10,923) | (11,370) |